| Literature DB >> 32210109 |
Dorota Kostrzewa-Nowak1, Andrzej Ciechanowicz2, Jeremy S C Clark2, Robert Nowak1.
Abstract
Inflammation-induced processes commence with the activation of signalling pathways at the cellular level, which mobilize inflammatory cells and stimulate the secretion of chemokines, cytokines, and damage-associated molecular pattern molecules (DAMPs). Physical effort stimulates inflammation, contributing to muscle repair and regeneration. We have examined the impact of different protocols of progressive-effort tests on T-cell DAMP levels, extracellular cleavage products (fibronectin and hyaluronan), and Th-cell-related cytokine levels among soccer players. Thirty male soccer players with a median age of 17 (16-22) years performed different defined protocols for progressive exercise until exhaustion: (1) YO-YO intermittent recovery test level 1 (YYRL1, n = 10); (2) maximal multistage 20 m shuttle run (Beep, n = 10); and mechanical treadmill (MT, n = 10); and (3) shuttle-run test (n = 10). Blood samples were taken three times as follows: at baseline, post effort, and in recovery. Significantly higher post-effort concentrations of IL-4, IL-6, IL-10, and IFN-γ were observed in the Beep group, IL-4 in the YYRL1 group, and IL-6 and IFN-γ in the MT group as compared with the baseline values. Recovery values were significantly higher for concentrations of IL-4, IL-10, and IFN-γ in the YYRL1 group, only for IFN-γ in the Beep group, and for IL-6, IL-10, and INF-γ in the MT group as compared with the baseline values. Post-effort concentrations of DEFβ2, Hsp27, Fn, and UA in the Beep group and Hsp27 and HA in the YYRL1 group were significantly higher as compared with the baseline values. It seems the performed efficiency test protocols caused a short-term imbalance in Th1/Th2 cytokine levels without giving common molecular patterns. The rapidity of these changes was apparently related to specific physical movements and the type of running surface.Entities:
Keywords: T lymphocytes; athletes; cytokines; damage-associated molecular patterns; progressive effort; soccer
Year: 2020 PMID: 32210109 PMCID: PMC7141504 DOI: 10.3390/jcm9030876
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Characteristics and cardiorespiratory fitness measures of participants during the progressive-effort-until-exhaustion tests.
| Variable | YYRL1 Group | Beep Group | MT Group | pKW 1 |
|---|---|---|---|---|
| Median (minimum – maximum) | ||||
| Age (years) | 17 (16–20) | 17 (16–22) | 18 (16–21) | 0.300 |
| Height (m) | 1.77 (1.67–1.89) | 1.78 (1.67–1.84) | 1.80 (1.60–1.89) | 0.710 |
| Mass 2 (kg) | 67.4 (56.6–82.2) | 72.3 (57.0–77.8) | 69.8 (56.4–85.2) | 0.818 |
| BMI 2 (kg/m2) | 21.6 (20.3–23.8) | 22.5 (20.3–23.3) | 21.8 (20.3–23.9) | 0.717 |
| FAT 2 (%) | 9.8 (4.8–17.4) | 9.2 (3.6–14.8) | 7.9 (2.2–12.6) | 0.818 |
| FAT MASS 2 (kg) | 6.3 (3.4–14.3) | 6.7 (2.2–10.8) | 5.5 (1.3–9.9) | 0.963 |
| FFM 2 (kg) | 62.1 (49.8–72.1) | 64.0 (52.7–69.2) | 65.5 (52.3–75.3) | 0.783 |
| TBW 2 (kg) | 45.5 (36.5–52.8) | 46.9 (38.6–50.7) | 48.0 (38.3–55.1) | 0.672 |
| Length of training experience (years) | 10.0 (8.0–13.0) | 10.5 (7.0–12.0) | 11.0 (5.0–13.0) | 0.863 |
| Weekly training volume (hours) | 12.0 (10.0–18.0) | 11.8 (9.5–12.5) | 12.0 (7.5–15.0) | 0.169 |
| HRmax (beats/min) | 202 (194–212) | 203 (197–217) | 199 (178–210) | 0.096 |
| VO2max (mL/kg/min) | 53.5 (46.5–58.6) | 53.0 (48.3–57.8) | 61.0 (55.8–67.3) | N.A. |
1 Differences observed between analyzed groups (YYRL1 vs. Beep vs. MT) assessed using Kruskal–Wallis analysis of ranks. 2 Body mass and composition determined using a body composition analyzer (Tanita BC-418MA, Tanita, Tokyo, Japan). N, number of participants; BMI, body mass index; FAT, estimated lipid amounts, FFM, fat free mass; HRmax, maximum heart rate; TBW, total body water; VO2max, maximum oxygen uptake; YYRL1, YO-YO intermittent recovery test level 1 protocol (see methods); Beep, maximal multistage 20 m shuttle run test; MT, efficiency test on a mechanical treadmill; N.A., not applicable. No statistical comparison of VO2max values among groups was performed due to differing methods of determination.
White blood cell (WBC), lymphocyte (LYM) counts, percentage of lymphocytes and T cells (CD3+) in studied participants’ blood samples.
| Variable | YYRL1 Group | Beep Group | MT Group | pKW 1 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | Post-Effort | Recovery | pF | Baseline | Post-Effort | Recovery | pF | Baseline | Post-Effort | Recovery | pF | ||
| Median (Minimum–Maximum) | Median (Minimum–Maximum) | Median (Minimum–Maximum) | |||||||||||
| WBC (109/L) | 5.3 | 7.8 | 5.8 |
| 5.4 | 8.6 | 6.0 |
| 5.3 | 8.8 | 5.8 |
|
|
| LYM (109/L) | 1.9 | 3.3 | 1.9 |
| 1.9 | 3.2 | 1.6 |
| 2.2 | 4.4 | 2.5 |
|
|
| LYM (%) | 24.7 | 24.1 | 20.6 |
| 16.8 | 17.4 | 15.0 |
| 20.5 | 29.6 | 20.9 |
|
|
| T cells (%) | 74.8 | 69.9 | 74.7 |
| 68.9 | 57.6 | 75.6 |
| 65.4 | 58.7 | 73.1 |
|
|
The analyses were performed before (baseline) and after the progressive effort (5 minutes post effort) and during recovery time (about 17 hours after the test). 1 Differences in baseline values among analyzed groups (YYRL1 vs. Beep vs. MT) were assessed using the Kruskal–Wallis analysis of ranks and the median test (pKW, Kruskal–Wallis p values). Significance levels of differences observed between analyzed time points (pre-exercise vs. post-exercise vs. recovery) were assessed using the Friedman’s analysis of variance for repeated measures (pF, Friedman’s ANOVA p values) followed by post-hoc Dunn’s test with Bonferroni correction. Post-hoc p values, A p < 0.05 for baseline vs. post-effort; B p < 0.05 for post-effort vs. recovery; C p < 0.05 for baseline vs. recovery. N, number of participants; Beep, maximal multistage 20 m shuttle run test; MT, efficiency test on mechanical treadmill; YYRL1, YO-YO intermittent recovery test level 1 protocol. For other abbreviations see Table 1.
Median levels of interleukin-2 (IL-2), interleukin-4 (IL-4), interleukin-6 (IL-6), interleukin-10 (IL-10), and interferon gamma (IFN-γ) in studied participants’ plasma samples.
| Variable | YYRL1 Group | Beep Group | MT Group | pKW 2 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | Post-Effort | Recovery | pF | Baseline | Post-Effort | Recovery | pF | Baseline | Post-Effort | Recovery | pF | ||
| Median (Minimum–Maximum) | Median (Minimum–Maximum) | Median (Minimum–Maximum) | |||||||||||
| IL-2 (pg/mL) | 2.7 | 2.6 | 4.6 | 0.061 | 1.5 | 3.9 | 1.2 | 0.067 | 5.9 | 3.3 | 6.0 | 0.020 | <0.001 |
| ratio 1 | 1.1 | 1.8 | 3.8 | 0.8 | 0.6 | 1.0 | <0.001 | ||||||
| IL-4 (pg/mL) | 1.2 | 1.7 | 2.5 | 0.001 | 1.4 | 13.1 | 7.2 | < 0.001 | 1.3 | 0.7 | 1.1 | 0.122 | 0.150 |
| ratio | 1.8 | 2.8 | 9.7 | 5.3 | 0.5 | 0.7 | <0.001 | ||||||
| IL-6 (pg/mL) | 1.4 | 3.1 | 2.1 | 0.061 | 0.4 | 13.1 | 2.1 | 0.002 | 1.3 | 4.7 | 4.0 | 0.002 | 0.039 |
| ratio | 2.3 | 1.3 | 34.0 | 5.5 | 2.9 | 3.5 | 0.004 | ||||||
| IL-10 (pg/mL) | 1.9 | 3.9 | 11.2 | < 0.001 | 1.8 | 5.9 | 3.3 | 0.007 | 1.5 | 1.9 | 5.2 | < 0.001 | 0.191 |
| ratio | 1.9 | 5.5 | 3.0 | 1.7 | 1.4 | 3.6 | 0.163 | ||||||
| IFN- | 1.7 | 1.7 | 13.5 | < 0.001 | 2.0 | 6.8 | 6.3 | 0.007 | 3.3 | 5.0 | 12.9 | < 0.001 | 0.003 |
| ratio | 1.0 | 7.8 | 4.2 | 2.5 | 1.5 | 3.8 | 0.002 | ||||||
| IFN-IL-4 | 1.8 | 1.0 | 6.3 | 0.002 | 1.3 | 0.5 | 1.1 | 0.202 | 2.3 | 8.2 | 11.0 | 0.002 | 0.076 |
| ratio | 0.5 | 3.7 | 0.4 | 0.6 | 2.8 | 5.2 | <0.001 | ||||||
1 Post-effort/baseline ratio or recovery/baseline ratio in “post-effort” column or “recovery” column, respectively. 2 Differences in baseline values or in ratio values among analyzed groups (YYRL1 vs. Beep vs. MT) were assessed using the Kruskal–Wallis analysis of ranks and the median test (pKW, Kruskal–Wallis p values for baseline values, post-effort/baseline ratio and for recovery/baseline ratio in upper row, middle row, or bottom row for each variable, respectively). For other abbreviations see Table 2.
Median levels of T cell intracellular DAMPs (defensing beta 2 (DEFβ2), heat shock 27 kDa protein 1 (Hsp27), thioredoxin (Trx)) and extracellular DAMPs (fibronectin (Fn), hyaluronan (HA), high mobility group protein 1 (HMG1), uric acid (UA)) in studied participants’ blood samples.
| Variable | YYRL1 Group | Beep Group | MT Group | pKW | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | Post-Effort | Recovery | pF | Baseline | Post-Effort | Recovery | pF | Baseline | Post-Effort | Recovery | pF | ||
| Median (Minimum–Maximum) | Median (Minimum–Maximum) | Median (Minimum–Maximum) | |||||||||||
| DEF2 (pg/mL) | 26.8 | 15.2 | 15.4 | 0.182 | 30.0 | 58.9 | 57.0 | 0.032 | 30.8 | 25.9 | 24.0 | 0.061 | 0.077 |
| ratio | 0.8 | 0.7 | 1.7 | 1.9 | 0.8 | 0.7 | <0.001 | ||||||
| Hsp27 (ng/mL) | 3.2 | 4.1 | 3.8 | 0.007 | 3.0 | 3.7 | 3.0 | 0.007 | 3.4 | 3.4 | 3.5 | 0.272 | 0.509 |
| ratio | 1.4 | 1.0 | 1.2 | 0.9 | 1.0 | 1.1 | 0.019 | ||||||
| Trx (ng/mL) | 21.3 | 25.1 | 28.2 | 0.082 | 30.3 | 17.4 | 26.3 | 0.272 | 10.6 | 15.9 | 21.8 | 0.670 | 0.034 |
| ratio | 1.1 | 1.5 | 0.7 | 0.7 | 1.7 | 1.8 | 0.071 | ||||||
| Fn (mg/mL) | 0.18 | 0.18 | 0.19 | 0.496 | 0.14 | 0.21 | 0.22 | 0.002 | 0.17 | 0.18 | 0.19 | 0.497 | 0.187 |
| ratio | 1.0 | 1.0 | 1.4 | 1.5 | 1.0 | 1.1 | <0.001 | ||||||
| HA (ng/mL) | 19.3 | 46.7 | 18.6 | < 0.001 | 12.4 | 23.9 | 12.3 | 0.061 | 17.3 | 18.4 | 24.7 | 0.150 | 0.284 |
| ratio | 2.7 | 1.0 | 1.8 | 1.2 | 1.0 | 1.9 | 0.122 | ||||||
| HMG1 (ng/mL) | 2.4 | 3.2 | 3.5 | 0.496 | 2.5 | 3.3 | 2.3 | 0.061 | 4.5 | 4.4 | 4.6 | 0.741 | <0.001 |
| ratio | 1.3 | 1.4 | 1.4 | 1.0 | 1.0 | 1.1 | 0.074 | ||||||
| UA (µmol/L) | 261 | 282 | 289 | 0.067 | 345 | 388 | 347 | 0.014 | 307 | 333 | 356 | 0.061 | 0.024 |
| ratio | 1.1 | 1.0 | 1.1 | 1.0 | 1.1 | 1.1 | 0.196 | ||||||
For abbreviations see Table 2 and Table 3.